Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2023.03.30
海普瑞：内部控制审计报告
2023.03.30
海普瑞：商誉减值报告
2023.03.30
海普瑞：监事会决议公告
2023.03.30
海普瑞：年度关联方资金占用专项审计报告
2023.03.30
海普瑞：关于开展以套期保值为目的的外汇衍生品交易的公告
2023.03.30
海普瑞：关于增加经营范围及修订《公司章程》的公告
2023.03.30
海普瑞：独立董事提名人声明（黄鹏）
2023.03.30
海普瑞：独立董事候选人声明（黄鹏）
2023.03.30
海普瑞：关于2023年度向银行申请授信额度暨提供担保的公告
2023.03.30
海普瑞：董事会决议公告
第一页
上一页
5
6
7
8
9
下一页
最后一页
